3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Mouth Neoplasms
3
Head and Neck Neoplasms
3
Neoplasms
2
Nasopharyngeal Carcinoma
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Sarcoma
1
Osteosarcoma
1
Nasopharyngeal Neoplasms
1
Lung Neoplasms
1
Hypoxia
1
Breast Neoplasms
1
Interventions
pembrolizumab
11
Nivolumab
6
Cetuximab
5
Gemcitabine
4
Filgrastim
4
Cisplatin
4
Carboplatin
4
tislelizumab
3
Radiosurgery
3
Ipilimumab
3
Injections
3
Fluorouracil
3
Docetaxel
3
Cyclophosphamide
3
Bortezomib
3
toripalimab
2
spartalizumab
2
poly ICLC
2
pazopanib
2
entrectinib
2
durvalumab
2
cemiplimab
2
belinostat
2
atezolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Riluzole
2
Peripheral Blood Stem Cell Transplantation
2
Oncolytic Virotherapy
2
Etoposide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Positron Emission Tomography Computed Tomography
×
Head & Neck
×
Clear all
NCT06726512
2024-12-10
qMAP
University Medical Center Groningen
Phase NA
Not yet recruiting
30 enrolled